BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30689037)

  • 1. Interobserver agreement of skeletal muscle mass measurement on head and neck CT imaging at the level of the third cervical vertebra.
    Bril SI; Wendrich AW; Swartz JE; Wegner I; Pameijer F; Smid EJ; Bol GH; Pothen AJ; de Bree R
    Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):1175-1182. PubMed ID: 30689037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of skeletal muscle mass assessment at the level of the third cervical vertebra in patients with head and neck cancer.
    Bril SI; Chargi N; Wendrich AW; Wegner I; Bol GH; Smid EJ; de Jong PA; Devriese LA; de Bree R
    Oral Oncol; 2021 Dec; 123():105617. PubMed ID: 34749251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer.
    Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2019 Aug; 95():95-99. PubMed ID: 31345401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal muscle mass and sarcopenia can be determined with 1.5-T and 3-T neck MRI scans, in the event that no neck CT scan is performed.
    Zwart AT; Becker JN; Lamers MJ; Dierckx RAJO; de Bock GH; Halmos GB; van der Hoorn A
    Eur Radiol; 2021 Jun; 31(6):4053-4062. PubMed ID: 33219847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prediction model for skeletal muscle evaluation and computed tomography-defined sarcopenia diagnosis in a predominantly overweight cohort of patients with head and neck cancer.
    Vangelov B; Bauer J; Moses D; Smee R
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):321-328. PubMed ID: 35835910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of skeletal muscle evaluation at the third cervical vertebral level for computed tomography-defined sarcopenia assessment in patients with head and neck cancer.
    Vangelov B; Bauer J; Moses D; Smee R
    Head Neck; 2022 May; 44(5):1047-1056. PubMed ID: 35138008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of software programmes for cross-sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patients.
    van Vugt JL; Levolger S; Gharbharan A; Koek M; Niessen WJ; Burger JW; Willemsen SP; de Bruin RW; IJzermans JN
    J Cachexia Sarcopenia Muscle; 2017 Apr; 8(2):285-297. PubMed ID: 27897414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The validation of low-dose CT scans from the [
    Zwart AT; Cavalheiro VJ; Lamers MJ; Dierckx RAJO; de Bock GH; Halmos GB; van der Hoorn A
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1735-1742. PubMed ID: 36781423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer.
    Yoon JK; Jang JY; An YS; Lee SJ
    PLoS One; 2021; 16(7):e0254844. PubMed ID: 34280248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal Muscle Mass Measurement Using Cone-Beam Computed Tomography in Patients With Head and Neck Cancer.
    Huang W; Tan P; Zhang H; Li Z; Lin H; Wu Y; Du Q; Wu Q; Cheng J; Liang Y; Pan Y
    Front Oncol; 2022; 12():902966. PubMed ID: 35837096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer.
    Zwart AT; van der Hoorn A; van Ooijen PMA; Steenbakkers RJHM; de Bock GH; Halmos GB
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1060-1069. PubMed ID: 31134765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients.
    Swartz JE; Pothen AJ; Wegner I; Smid EJ; Swart KM; de Bree R; Leenen LP; Grolman W
    Oral Oncol; 2016 Nov; 62():28-33. PubMed ID: 27865369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of alternate vertebral levels to L3 in computed tomography scans for skeletal muscle mass evaluation and sarcopenia assessment in patients with cancer: a systematic review.
    Vangelov B; Bauer J; Kotevski D; Smee RI
    Br J Nutr; 2022 Mar; 127(5):722-735. PubMed ID: 33910664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low skeletal muscle mass assessed directly from the 3rd cervical vertebra can predict pharyngocutaneous fistula risk after total laryngectomy in the male population.
    Casasayas M; García-Lorenzo J; Gómez-Ansón B; Medina V; Fernández A; Quer M; León X
    Eur Arch Otorhinolaryngol; 2022 Feb; 279(2):853-863. PubMed ID: 34665301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenia and its impact in head and neck cancer treatment.
    de Bree R; van Beers MA; Schaeffers AWMA
    Curr Opin Otolaryngol Head Neck Surg; 2022 Apr; 30(2):87-93. PubMed ID: 35255045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of muscle mass in the legs of patients with peripheral arterial occlusive disease: associations between volumetric and cross-sectional single-slice measurements for identification of atrophy and focal sarcopenia.
    Ma KF; Berends B; Vedder IR; Levolger S; Gupta M; Schuurmann RC; de Vries JPPM; Bokkers RP
    J Cardiovasc Surg (Torino); 2019 Dec; 60(6):672-678. PubMed ID: 31603293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of assessment of skeletal muscle mass on a single cross-sectional image at the level of the fourth thoracic vertebra.
    van Heusden HC; Swartz JE; Chargi N; de Jong PA; van Baal MCPM; Wegner I; de Bree R
    Eur J Radiol; 2021 Sep; 142():109879. PubMed ID: 34343845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate estimation of skeletal muscle mass by comparison of computed tomographic images of the third lumbar and third cervical vertebrae in Japanese patients with oral squamous cell carcinoma.
    Ohashi N; Koike K; Sakai K; Nishiyama K; Sasaki T; Ogi K; Dehari H; Kobayashi N; Miyazaki A
    Oral Radiol; 2023 Apr; 39(2):408-417. PubMed ID: 36114388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer.
    Wendrich AW; Swartz JE; Bril SI; Wegner I; de Graeff A; Smid EJ; de Bree R; Pothen AJ
    Oral Oncol; 2017 Aug; 71():26-33. PubMed ID: 28688687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability and Validity of Abdominal Skeletal Muscle Area Measurement Using Magnetic Resonance Imaging.
    Wang FZ; Sun H; Zhou J; Sun LL; Pan SN
    Acad Radiol; 2021 Dec; 28(12):1692-1698. PubMed ID: 33129660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.